[go: up one dir, main page]

FI65775C - Foerfarande foer framstaellning av terapeutiskt anvaendbara prpenylaminer - Google Patents

Foerfarande foer framstaellning av terapeutiskt anvaendbara prpenylaminer Download PDF

Info

Publication number
FI65775C
FI65775C FI802583A FI802583A FI65775C FI 65775 C FI65775 C FI 65775C FI 802583 A FI802583 A FI 802583A FI 802583 A FI802583 A FI 802583A FI 65775 C FI65775 C FI 65775C
Authority
FI
Finland
Prior art keywords
formula
group
hydrogen
trans
compound
Prior art date
Application number
FI802583A
Other languages
English (en)
Finnish (fi)
Other versions
FI65775B (fi
FI802583A (fi
Inventor
Anton Stuetz
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4328536&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI65775(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI802583A publication Critical patent/FI802583A/fi
Application granted granted Critical
Publication of FI65775B publication Critical patent/FI65775B/fi
Publication of FI65775C publication Critical patent/FI65775C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/04—Acyclic alcohols with carbon-to-carbon triple bonds
    • C07C33/048—Acyclic alcohols with carbon-to-carbon triple bonds with double and triple bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/05—Alcohols containing rings other than six-membered aromatic rings
    • C07C33/12—Alcohols containing rings other than six-membered aromatic rings containing five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/12—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with only hydrogen atoms attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/08—Hydrogen atoms or radicals containing only hydrogen and carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/58—Radicals substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Indole Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Replacement Of Web Rolls (AREA)
  • Radiation-Therapy Devices (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
FI802583A 1979-08-22 1980-08-15 Foerfarande foer framstaellning av terapeutiskt anvaendbara prpenylaminer FI65775C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH765679 1979-08-22
CH765679 1979-08-22

Publications (3)

Publication Number Publication Date
FI802583A FI802583A (fi) 1981-02-23
FI65775B FI65775B (fi) 1984-03-30
FI65775C true FI65775C (fi) 1984-07-10

Family

ID=4328536

Family Applications (1)

Application Number Title Priority Date Filing Date
FI802583A FI65775C (fi) 1979-08-22 1980-08-15 Foerfarande foer framstaellning av terapeutiskt anvaendbara prpenylaminer

Country Status (24)

Country Link
US (1) US4755534A (pt)
EP (1) EP0024587B1 (pt)
JP (2) JPS5632440A (pt)
AT (1) ATE10272T1 (pt)
AU (1) AU538928B2 (pt)
CA (1) CA1157023A (pt)
CY (1) CY1410A (pt)
DE (3) DE19375084I2 (pt)
DK (1) DK153470C (pt)
ES (1) ES494408A0 (pt)
FI (1) FI65775C (pt)
HK (1) HK21588A (pt)
IE (1) IE50878B1 (pt)
IL (1) IL60877A (pt)
KE (1) KE3775A (pt)
LU (1) LU88343I2 (pt)
MY (1) MY8600181A (pt)
NL (1) NL930136I2 (pt)
NZ (1) NZ194714A (pt)
PH (1) PH22166A (pt)
PT (1) PT71717B (pt)
SG (1) SG89287G (pt)
YU (1) YU41513B (pt)
ZA (1) ZA805185B (pt)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5132459A (en) * 1979-08-22 1992-07-21 Sandoz Ltd. Propenylamines, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
CH653028A5 (de) * 1982-02-03 1985-12-13 Sandoz Ag Benzthiophenallylamin-verbindungen und verfahren zu ihrer herstellung.
FR2526423B1 (fr) * 1982-05-07 1987-07-10 Sandoz Sa Nouvelles amines insaturees, leur preparation et leur utilisation comme medicaments
JPS6145A (ja) * 1984-06-09 1986-01-06 Kaken Pharmaceut Co Ltd Ｎ‐（４‐ｔｅｒｔ‐ブチルベンジル）‐Ｎ‐メチル‐１‐ナフチルメチルアミンおよびそれを有効成分とする抗真菌剤
EP0191269B1 (en) * 1984-11-22 1991-03-06 Sandoz Ag Novel homopropargylamines
CH672311A5 (pt) * 1985-09-14 1989-11-15 Sandoz Ag
NL8700083A (nl) * 1986-01-29 1987-08-17 Sandoz Ag Tegen schimmels werkende aminen, werkwijzen voor de bereiding daarvan en hun toepassing.
US4751245A (en) * 1986-06-25 1988-06-14 E. R. Squibb & Sons, Inc. Antifungal derivatives of N-(6,6-dimethyl-2-hepten-4-ynyl)-1-naphthalenemethanamine and method of using same
EP0254677A1 (en) * 1986-07-08 1988-01-27 Sandoz Ag Antimycotic 6-phenyl-2-hexen-4-ynamines
JPS63238060A (ja) * 1987-03-26 1988-10-04 Maruho Kk キノリン誘導体
ZA885824B (en) * 1987-08-14 1989-04-26 Merrell Dow Pharma Novel antidepressants
US5149714A (en) * 1987-08-14 1992-09-22 Merrell Dow Pharmaceuticals Inc. Antidepressants
NZ227042A (en) 1987-11-27 1991-05-28 Banyu Pharma Co Ltd Substituted alkylamine derivatives and pharmaceutical compositions
US5234946A (en) * 1987-11-27 1993-08-10 Banyu Pharmaceutical Co., Ltd. Substituted alkylamine derivatives
EP0363326A3 (en) * 1988-10-07 1991-10-09 Sandoz Ag Fungicidal amines
DE69011139T2 (de) * 1989-01-12 1995-03-09 Sumitomo Chemical Co Aromatische Allylanim enthaltende warmhärtende Harzzusammensetzung.
JP3116364B2 (ja) * 1989-10-02 2000-12-11 萬有製薬株式会社 エンイン誘導体の製造法
FR2673537B1 (fr) * 1991-03-08 1993-06-11 Oreal Utilisation d'agents de penetration hydrophiles dans les compositions dermatologiques pour le traitement des onychomycoses, et compositions correspondantes.
HU223343B1 (hu) * 1991-05-20 2004-06-28 Novartis Ag. Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására
HU219480B (hu) * 1991-05-23 2001-04-28 Novartis Ag. Eljárás gombás körömmegbetegségek ellen helyileg alkalmazható, allil-amin-származékot tartalmazó gyógyászati készítmények előállítására
GB9111611D0 (en) * 1991-05-30 1991-07-24 Sandoz Ltd Liposomes
JPH04138020U (ja) * 1991-06-14 1992-12-24 日立機材株式会社 バケツトエレベータ
GB9513750D0 (en) * 1995-07-06 1995-09-06 Sandoz Ltd Use of allylamines
NZ280065A (en) * 1995-09-20 1998-04-27 Apotex Inc Preparation of n-alkyl-n-(1-naphthylmethyl)alk-2-en-4-ynylamine derivatives
US6075056A (en) * 1997-10-03 2000-06-13 Penederm, Inc. Antifungal/steroid topical compositions
SK5202000A3 (en) 2000-04-07 2001-12-03 Slovakofarma As Method for the preparation of (e)-n-(6,6-dimethyl-2-hepten-4- inyl)-n-methyl-1-naphthalenemethylamine (terbinaphin)
IL152696A0 (en) * 2000-06-09 2003-06-24 Bayer Cropscience Sa Process for the preparation of pesticidal compounds
IL137364A (en) * 2000-07-18 2005-08-31 Chemagis Ltd Process for the preparation of 6,6-dimethylhept-1-en-4-yn-3-ol
GB0103046D0 (en) 2001-02-07 2001-03-21 Novartis Ag Organic Compounds
US7244703B2 (en) * 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
KR100459275B1 (ko) 2001-12-28 2004-12-03 주식회사유한양행 터비나핀 또는 그의 염산염의 제조방법
BG65097B1 (bg) * 2002-03-15 2007-02-28 Richter Gedeon Vegyeszeti Gyar Rt. Метод за получаване на заместено производно на алиламин и на съответните му соли
US8404751B2 (en) 2002-09-27 2013-03-26 Hallux, Inc. Subunguicide, and method for treating onychomycosis
DE602004021253D1 (de) 2003-03-21 2009-07-09 Nexmed Holdings Inc Antimykotischer nagellack und anwendungsverfahren
GB0320312D0 (en) * 2003-08-29 2003-10-01 Novartis Ag Purification process
GB0503942D0 (en) * 2005-02-25 2005-04-06 Novartis Ag Purification process
US20050197512A1 (en) * 2003-08-29 2005-09-08 Ulrich Beutler Purification process
DE602004028284D1 (de) 2003-12-08 2010-09-02 Cpex Pharmaceuticals Inc Pharmazeutische zusammensetzungen und verfahren für die insulinbehandlung
ES2245596B1 (es) * 2004-06-10 2007-07-01 Ercros Industrial, S.A. Procedimiento para la obtencion de clorhidrato de terbinafina.
US20060004230A1 (en) * 2004-06-30 2006-01-05 Joseph Kaspi Process for the preparation of terbinafine and salts thereof
CA2570245A1 (en) * 2004-07-02 2006-01-12 Warner-Lambert Company Llc Compositions and methods for treating pathological infections
US20060078580A1 (en) * 2004-10-08 2006-04-13 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US7740875B2 (en) * 2004-10-08 2010-06-22 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
CN1293037C (zh) * 2004-11-03 2007-01-03 浙江海正药业股份有限公司 一种制备特比萘芬盐酸盐的方法
JP2009502258A (ja) * 2005-07-21 2009-01-29 ノミール・メディカル・テクノロジーズ・インコーポレーテッド 標的部位の生物学的汚染物質のレベルを下げる方法
JP2010512343A (ja) * 2006-12-08 2010-04-22 オースペックス・ファーマシューティカルズ・インコーポレイテッド 置換アリルアミン類の調製および実用性
US20080176908A1 (en) * 2007-01-18 2008-07-24 Mcanally Weylan R Method of using squalene monooxygenase inhibitors to treat acne
US20090082469A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched terbinafine
JP2011529038A (ja) * 2008-07-23 2011-12-01 ターゲッティド デリバリー テクノロジーズ リミテッド 真菌感染症の処置のための局所抗真菌製剤の投与方法
EP2730271B1 (en) 2012-11-11 2018-01-24 Symrise AG Aqeuous compositions
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
ES2701758T3 (es) 2013-02-27 2019-02-25 Symrise Ag Extracto de jengibre para la protección de citoblastos
WO2014159060A1 (en) 2013-03-14 2014-10-02 Hallux, Inc. Method of treating infections, diseases or disorders of nail unit
EP2862852B1 (en) 2013-10-18 2018-07-04 Symrise AG Urea derivatives for the protection of stem cells
EP2921157B1 (en) 2014-03-18 2017-08-16 Symrise AG Coated titanium dioxide to reduce whitening effect on skin
EP2939710B1 (en) 2014-04-29 2020-06-17 Symrise AG Active Mixtures
EP3045161A1 (en) 2015-01-18 2016-07-20 Symrise AG Active compositions comprising 1,2-hexanediol and 1,2-octanediol
CN104725240B (zh) * 2015-02-12 2017-05-24 吉林修正药业新药开发有限公司 一种盐酸特比萘芬z型异构体的制备方法
CN108084125B (zh) * 2016-11-23 2020-08-18 华东理工大学 苯并杂环烷基胺类化合物及其用途
CN114727689B (zh) 2019-11-12 2023-11-03 Ykk株式会社 拉链

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE623609A (pt) * 1961-10-27
DE2716943C2 (de) * 1976-04-28 1986-08-14 Sandoz-Patent-GmbH, 7850 Lörrach N-(3-Phenyl-2-propenyl)-N-(1-naphthylmethyl)-amine, ihre Verwendung und Herstellung
EP0000896B1 (en) * 1977-08-19 1982-10-13 Sandoz Ag Propenyl amines, processes for their production and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
IL60877A0 (en) 1980-10-26
CA1157023A (en) 1983-11-15
PH22166A (en) 1988-06-28
MY8600181A (en) 1986-12-31
ATE10272T1 (de) 1984-11-15
ZA805185B (en) 1982-03-31
DK357980A (da) 1981-02-23
DK153470B (da) 1988-07-18
HK21588A (en) 1988-03-31
YU209680A (en) 1983-10-31
IE801770L (en) 1981-02-22
DE19375084I2 (de) 2000-11-16
JPS6342612B2 (pt) 1988-08-24
DE19975055I1 (de) 2000-01-27
DK153470C (da) 1988-11-28
EP0024587B1 (en) 1984-11-14
PT71717A (en) 1980-09-01
NL930136I2 (nl) 1998-10-01
AU538928B2 (en) 1984-09-06
NZ194714A (en) 1984-11-09
IL60877A (en) 1984-08-31
DE3069633D1 (en) 1984-12-20
LU88343I2 (fr) 1994-05-04
EP0024587A1 (en) 1981-03-11
IE50878B1 (en) 1986-08-06
JPS5632440A (en) 1981-04-01
ES8105694A1 (es) 1981-06-16
KE3775A (en) 1987-11-27
PT71717B (en) 1981-09-24
ES494408A0 (es) 1981-06-16
NL930136I1 (nl) 1993-11-01
SG89287G (en) 1988-09-30
FI65775B (fi) 1984-03-30
YU41513B (en) 1987-08-31
CY1410A (en) 1988-04-22
US4755534A (en) 1988-07-05
AU6159280A (en) 1981-04-16
JPS63313753A (ja) 1988-12-21
JPH0415216B2 (pt) 1992-03-17
FI802583A (fi) 1981-02-23

Similar Documents

Publication Publication Date Title
FI65775C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara prpenylaminer
Nussbaumer et al. Synthesis and structure-activity relationships of side-chain-substituted analogs of the allylamine antimycotic terbinafine lacking the central amino function
FI65774C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara prpenylaminer
FI65058C (fi) Foerfarande foer framstaellning av nya kemoterapeutiskt anvaendbara kinnamyl-(1-naftylmetyl)aminoderivat
US5691340A (en) Benzopyran derivatives
Sakamoto et al. Condensed heteroaromatic ring systems. XVIII. Palladium-catalyzed cross-coupling reaction of aryl bromides with (Z)-1-ethoxy-2-tributylstannylethene and its utilization for construction of condensed heteroaromatics
Pascal et al. Antimitotic agents interacting with tubulin: Synthesis and structure-activity relationships of novel ortho bridged biphenyls of the rhazinilam type
JP2014520901A (ja) ４−置換イミダゾールの新規な調製プロセス
Carocci et al. Stereospecific synthesis of mexiletine and related compounds: Mitsunobu versus Williamson reaction
Nussbaumer et al. Synthesis and structure-activity relationships of phenyl-substituted benzylamine antimycotics: a novel benzylbenzylamine antifungal agent for systemic treatment
JP5565667B2 (ja) 新規ジヒドロナフタレン化合物及びその用途
NZ219069A (en) Amine derivatives useful as a systemic antimycotic or an agrofungicide
KR20040106560A (ko) 인돌 유도체 및 ｃｂ2 수용체 리간드로서 그의 용도
CN103073559B (zh) 手性芳香螺缩酮类化合物及其制备方法和应用
FI80689B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara bensotienyldialkylallylaminderivat.
US4742077A (en) Bicyclic allylether derivatives, processes for their production and their use
CN106946814B (zh) 1-环己氧基-4-羟基-2,2,6,6-四甲基哌啶醇的提纯方法
HUE028471T2 (en) Method and intermediate products for the preparation of agomelatine
JP2017144424A (ja) 触媒、アミド結合の形成方法、及びアミド化合物の製造方法
WO2015081920A1 (en) Process for preparing lurasidone and intermediate thereof
Machida et al. Synthesis of 5-alkylidene-6-(dimethylamino) methyl-1, 3-cyclohexadienes from α-substituted benzyldimethylammoniomethylides
Schöllkopf et al. Asymmetric Syntheses via Heterocyclic Intermediates; XXI1. Enantioselective Synthesis of α-Alkylleucine Methyl Esters using the Bis-lactim Ether of Cyclo (L-Leu-L-Leu) as Starting Material
GB2120663A (en) Allylamine derivatives, processes for their preparation and their use
KR20070000387A (ko) 방향족 불포화 화합물의 제조 방법
KR20060136357A (ko) 방향족 불포화 화합물의 제조 방법

Legal Events

Date Code Title Description
ND Supplementary protection certificate (spc) granted
SPCG Supplementary protection certificate granted

Spc suppl protection certif: L44

Extension date: 20050815

PC Transfer of assignment of patent

Owner name: NOVARTIS AG

MA Patent expired

Owner name: NOVARTIS AG